Oxidized low-density lipoprotein associates with cardiovascular disease by a vicious cycle of atherosclerosis and inflammation: A systematic review and meta-analysis
Frontiers in Cardiovascular Medicine · 16.01.2023 · 9
DOI: 10.3389/fcvm.2022.1023651 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 16.01.2023. Verfasst von Christin G Hong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Section of Inflammation and Cardiometabolic Diseases, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, United …. Die Arbeit wurde bisher 78-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Low-density lipoprotein cholesterol (LDL-C) is an established marker for cardiovascular disease (CVD) and a therapeutic target. Oxidized LDL (oxLDL) is known to be associated with excessive inflammation and abnormal lipoprotein metabolism. Chronic inflammatory diseases confer an elevated risk of premature atherosclerosis and adverse cardiovascular events. Whether oxLDL may serve as a potential biomarker for CVD stratification in populations with chronic inflammatory conditions remains understudied.
Objective
To perform a systematic review and meta-analysis evaluating the relationship between oxLDL and CVD (defined by incident CVD events, carotid intima-media thickness, presence of coronary plaque) in patients with chronic inflammatory diseases.
Methods
A systematic literature search was performed using studies published between 2000 and 2022 from PubMed, Cochrane Library, Embase (Elsevier), CINHAL (EBSCOhost), Scopus (Elsevier), and Web of Science: Core Collection (Clarivate Analytics) databases on the relationship between oxLDL and cardiovascular risk on inflamed population. The pooled effect size was combined using the random effect model and publication bias was assessed if P < 0.05 for the Egger or Begg test along with the funnel plot test.
Results
A total of three observational studies with 1,060 participants were ultimately included in the final meta-analysis. The results demonstrated that oxLDL is significantly increased in participants with CVD in the setting of chronic inflammatory conditions. This meta-analysis suggests that oxLDL may be a useful biomarker in risk stratifying cardiovascular disease in chronically inflamed patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Section of Inflammation and Cardiometabolic Diseases, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, United States.
Zitieren
APA
Hong, C. G., Florida, E., Li, H., Parel, P. M., Mehta, N. N., & Sorokin, A. V. (2023). Oxidized low-density lipoprotein associates with cardiovascular disease by a vicious cycle of atherosclerosis and inflammation: A systematic review and meta-analysis. Frontiers in Cardiovascular Medicine, 9. https://doi.org/10.3389/fcvm.2022.1023651
Vancouver
Hong CG, Florida E, Li H, Parel PM, Mehta NN, Sorokin AV. Oxidized low-density lipoprotein associates with cardiovascular disease by a vicious cycle of atherosclerosis and inflammation: A systematic review and meta-analysis. Frontiers in Cardiovascular Medicine. 2023;9. doi:10.3389/fcvm.2022.1023651
BibTeX
@article{Hong2023,
author = {Hong, Christin G and Florida, Elizabeth and Li, Haiou and Parel, Philip M and Mehta, Nehal N and Sorokin, Alexander V},
title = {Oxidized low-density lipoprotein associates with cardiovascular disease by a vicious cycle of atherosclerosis and inflammation: A systematic review and meta-analysis},
journal = {Frontiers in Cardiovascular Medicine},
year = {2023},
volume = {9},
doi = {10.3389/fcvm.2022.1023651}
}
EUVIMED